2020

The Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) recently published its Semiannual Report…

Recently, the US Food and Drug Administration (“FDA”) issued a guidance regarding the effects of the COVID-19 crisis on formal…

As part of the CARES Act in response to the COVID-19 pandemic reaching the United States, Congress set aside $175 billion in…

The National Institutes of Health (“NIH”) and the Foundation for the NIH recently announced a public-private partnership,…

On May 28, 2020, the United States Court of Appeals for the Fifth Circuit affirmed a lower district court decision to dismiss the…

While the health of Americans overall has improved dramatically over the past century, these gains have not been shared equally,…

The fact that physicians and other providers have relationships with the pharmaceutical industry is a long-standing source of…

A survey of physicians and practice administrators reveals the deep impact of COVID-19 on ambulatory care offices across the…

With the COVID-19 pandemic hitting countries around the world hard, the United States Food and Drug Administration (FDA) has its…

A recent analysis conducted by Pacific Research Institute and Wayne Winegarden, PhD, found that if biosimilars reached 75% market…